These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 23812222

  • 1. Inhibition of nitric oxide synthesis enhances teratogenic effects induced by valproic Acid.
    Tiboni GM, Chiarelli F, Verrotti A.
    In Vivo; 2013; 27(4):513-8. PubMed ID: 23812222
    [Abstract] [Full Text] [Related]

  • 2. Prevention of valproic acid-induced neural tube defects by sildenafil citrate.
    Tiboni GM, Ponzano A.
    Reprod Toxicol; 2015 Aug 15; 56():175-9. PubMed ID: 25797655
    [Abstract] [Full Text] [Related]

  • 3. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A, Noyori H, Yagen B, Shimshoni JA, Bialer M, Fujiwara M.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct 15; 86(5):394-401. PubMed ID: 19830722
    [Abstract] [Full Text] [Related]

  • 4. Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
    Lin YL, Bialer M, Cabrera RM, Finnell RH, Wlodarczyk BJ.
    Birth Defects Res; 2019 Aug 15; 111(14):1013-1023. PubMed ID: 30325584
    [Abstract] [Full Text] [Related]

  • 5. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
    Okada A, Kurihara H, Aoki Y, Bialer M, Fujiwara M.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Feb 15; 71(1):47-53. PubMed ID: 14991910
    [Abstract] [Full Text] [Related]

  • 6. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U, Volland J, Nau H.
    Neurotoxicol Teratol; 2008 Feb 15; 30(5):390-4. PubMed ID: 18455366
    [Abstract] [Full Text] [Related]

  • 7. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V, Wlodarczyk B, Giavini E, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2006 Mar 15; 76(3):200-4. PubMed ID: 16511884
    [Abstract] [Full Text] [Related]

  • 8. Valproic acid alters nitric oxide status in neurulating mouse embryos.
    Tiboni GM, Ponzano A, Ferrone A, Franceschelli S, Speranza L, Patruno A.
    Reprod Toxicol; 2021 Jan 15; 99():152-159. PubMed ID: 33157224
    [Abstract] [Full Text] [Related]

  • 9. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
    Jergil M, Forsberg M, Salter H, Stockling K, Gustafson AL, Dencker L, Stigson M.
    Toxicol Sci; 2011 Jun 15; 121(2):328-42. PubMed ID: 21427059
    [Abstract] [Full Text] [Related]

  • 10. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E, Broccia ML, Nau H, Prati M, Ricolfi R, Giavini E.
    Teratog Carcinog Mutagen; 1996 Jun 15; 16(2):97-108. PubMed ID: 8875740
    [Abstract] [Full Text] [Related]

  • 11. Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects.
    Jergil M, Kultima K, Gustafson AL, Dencker L, Stigson M.
    Toxicol Sci; 2009 Mar 15; 108(1):132-48. PubMed ID: 19136453
    [Abstract] [Full Text] [Related]

  • 12. The nitric oxide synthesis inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: protective effect of acute hyperoxia.
    Tiboni GM, Giampietro F, Di Giulio C.
    Pediatr Res; 2003 Jul 15; 54(1):69-76. PubMed ID: 12700363
    [Abstract] [Full Text] [Related]

  • 13. Production of axial skeletal malformations with the nitric oxide synthesis inhibitor NG-nitro-L-arginine methyl ester (L-NAME) in the mouse.
    Tiboni GM, Marotta F, Barbacane L.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb 15; 80(1):28-33. PubMed ID: 17294455
    [Abstract] [Full Text] [Related]

  • 14. Teratology study of amide derivatives of branched aliphatic carboxylic acids with 4-aminobenzensulfonamide in NMRI mice.
    Onishi Y, Okada A, Noyori H, Okamura A, Hen N, Yagen B, Bialer M, Fujiwara M.
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug 15; 98(4):318-27. PubMed ID: 24039104
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
    Menegola E, Di Renzo F, Broccia ML, Prudenziati M, Minucci S, Massa V, Giavini E.
    Birth Defects Res B Dev Reprod Toxicol; 2005 Oct 15; 74(5):392-8. PubMed ID: 16193500
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice.
    Nau H, Löscher W.
    Fundam Appl Toxicol; 1986 May 15; 6(4):669-76. PubMed ID: 3086174
    [Abstract] [Full Text] [Related]

  • 17. Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats.
    Fisher JE, Acuff-Smith KD, Schilling MA, Nau H, Vorhees CV.
    Teratology; 1994 Jun 15; 49(6):479-86. PubMed ID: 7747269
    [Abstract] [Full Text] [Related]

  • 18. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M, Shirota M, Nagao T.
    Teratology; 1995 Sep 15; 52(3):143-8. PubMed ID: 8638254
    [Abstract] [Full Text] [Related]

  • 19. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A, Göttlicher M, Nau H.
    ALTEX; 2001 Sep 15; 18(2):123-6. PubMed ID: 11378687
    [Abstract] [Full Text] [Related]

  • 20. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
    Elmazar MM, Thiel R, Nau H.
    Fundam Appl Toxicol; 1992 Apr 15; 18(3):389-94. PubMed ID: 1597263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.